Target intelligence / Profile preview

Host intestinal epithelial cell-surface glycoproteins and mucins

Molecular classification
Mucin, Glycoprotein, Receptor, Barrier protein
01

Overview

Host intestinal epithelial cell-surface glycoproteins and mucins represent a diverse class of glycoconjugates that form the essential protective interface between the mammalian host and the external environment of the gut lumen (McGuckin et al., 2011). This system includes large, gel-forming secreted mucins, primarily MUC2, and a dense glycocalyx composed of membrane-tethered mucins such as MUC1, MUC4, and MUC17 (Corfield, 2015). These molecules function as a physical and chemical barrier, preventing the direct contact of digestive enzymes and toxins with the epithelial monolayer while also serving as a scaffold for antimicrobial peptides and immunoglobulin A (Johansson et al., 2011). Beyond their structural role, the specific glycan motifs on these proteins act as receptors for microbial adhesins, determining the composition of the commensal microbiota and the susceptibility to enteric pathogens (Juge, 2012). Dysregulation of mucin expression or altered glycosylation is a hallmark of inflammatory bowel diseases and is implicated in the progression of colorectal malignancies (Boltin et al., 2013). Pharmacological intervention typically involves the use of mucosal protectants like rebamipide, which enhances mucin secretion, or mucolytic agents like N-acetylcysteine, which modulate mucus viscosity for therapeutic purposes (Naito et al., 2010).

Other names
Intestinal mucus barrierGastrointestinal glycocalyxCell-surface glycoconjugatesEnterocyte surface mucinsIntestinal mucosal barrierMucin-glycan barrier
02

Mechanism of action

Stimulation of mucin synthesis and secretion, physical binding to surface glycoproteins to create a protective barrier, or chemical reduction of disulfide bonds to alter mucus rheology.

03

Biological functions

Barrier functionCell adhesionImmune modulationLubricationPathogen sequestrationMicrobiota niche maintenance
04

Disease associations

InfectionInflammationCancerPeptic ulcer diseaseInflammatory bowel disease
05

Safety considerations

Compromised barrier integrity leading to bacterial translocationDisruption of commensal microbial nichesPotential for systemic absorption of mucoadhesive compoundsRisk of mucosal erosion with excessive mucolytic use
06

Interacting drugs

Rebamipide

5 more in the full profile.

07

Biomarkers

MUC2 expressionFecal mucin concentrationO-glycan sulfation profilesTrefoil factor 3 (TFF3)

Beyond the preview

Go deeper on Host intestinal epithelial cell-surface glycoproteins and mucins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host intestinal epithelial cell-surface glycoproteins and mucins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call